BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26107473)

  • 1. Outcome of Boston Keratoprosthesis in a Developing Country-Importance of Patient Selection, Education, and Perioperative Care: The Indian Experience.
    Iyer G; Srinivasan B; Gupta N; Padmanabhan P
    Asia Pac J Ophthalmol (Phila); 2012; 1(4):202-7. PubMed ID: 26107473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boston keratoprosthesis for keratopathy in eyes with retained silicone oil: a new indication.
    Iyer G; Srinivasan B; Gupta J; Rishi P; Sen PR; Bhende P; Gopal L; Padmanabhan P
    Cornea; 2011 Oct; 30(10):1083-7. PubMed ID: 21705878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boston type 1 keratoprosthesis: the university of california davis experience.
    Bradley JC; Hernandez EG; Schwab IR; Mannis MJ
    Cornea; 2009 Apr; 28(3):321-7. PubMed ID: 19387235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratoprostheses in silicone oil-filled eyes: long-term outcomes.
    Iyer G; Srinivasan B; Agarwal S; Pattanaik R; Rishi E; Rishi P; Shanmugasundaram S; Natarajan V
    Br J Ophthalmol; 2019 Jun; 103(6):781-788. PubMed ID: 30021817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with Boston keratoprosthesis type 1 in the developing world.
    de Oliveira LA; Pedreira Magalhães F; Hirai FE; de Sousa LB
    Can J Ophthalmol; 2014 Aug; 49(4):351-7. PubMed ID: 25103652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
    Greiner MA; Li JY; Mannis MJ
    Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
    Aldave AJ; Kamal KM; Vo RC; Yu F
    Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Visual Outcomes and Complications of Boston Keratoprosthesis Type II Implantation.
    Lee R; Khoueir Z; Tsikata E; Chodosh J; Dohlman CH; Chen TC
    Ophthalmology; 2017 Jan; 124(1):27-35. PubMed ID: 27538795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results from the multicenter Boston Type 1 Keratoprosthesis Study.
    Zerbe BL; Belin MW; Ciolino JB;
    Ophthalmology; 2006 Oct; 113(10):1779.e1-7. PubMed ID: 16872678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International results with the Boston type I keratoprosthesis.
    Aldave AJ; Sangwan VS; Basu S; Basak SK; Hovakimyan A; Gevorgyan O; Kharashi SA; Jindan MA; Tandon R; Mascarenhas J; Malyugin B; Padilla MD; Maskati Q; Agarwala N; Hutauruk J; Sharma M; Yu F
    Ophthalmology; 2012 Aug; 119(8):1530-8. PubMed ID: 22512986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boston type 1 keratoprosthesis combined with silicone oil for treatment of hypotony in prephthisical eyes.
    Chan CC; Holland EJ; Sawyer WI; Neff KD; Petersen MR; Riemann CD
    Cornea; 2011 Oct; 30(10):1105-9. PubMed ID: 21642848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
    Pujari S; Siddique SS; Dohlman CH; Chodosh J
    Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric keratoprosthesis.
    Aquavella JV; Gearinger MD; Akpek EK; McCormick GJ
    Ophthalmology; 2007 May; 114(5):989-94. PubMed ID: 17467531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure.
    Kang JJ; de la Cruz J; Cortina MS
    Cornea; 2012 Dec; 31(12):1436-40. PubMed ID: 22367042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boston Type 2 keratoprosthesis- mid term outcomes from a tertiary eye care centre in India.
    Iyer G; Srinivasan B; Agarwal S; Ravindran R; Rishi E; Rishi P; Krishnamoorthy S
    Ocul Surf; 2019 Jan; 17(1):50-54. PubMed ID: 30157458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
    Sejpal K; Yu F; Aldave AJ
    Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anatomical survival and visual prognosis of Boston type I keratoprosthesis in challenging cases.
    de la Paz MF; Stoiber J; de Rezende Couto Nascimento V; de Toledo JA; Seyeddain O; Hitzl W; Grabner G; Barraquer RI; Michael R
    Graefes Arch Clin Exp Ophthalmol; 2014 Jan; 252(1):83-90. PubMed ID: 24390466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boston keratoprosthesis type I in the elderly.
    Homayounfar G; Grassi CM; Al-Moujahed A; Colby KA; Dohlman CH; Chodosh J
    Br J Ophthalmol; 2017 Apr; 101(4):514-518. PubMed ID: 27381593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of the MICOF keratoprosthesis surgery.
    Wang L; He X; Wang Q; Wu T; Liu A; Huang Y
    Ocul Surf; 2021 Jul; 21():178-185. PubMed ID: 34118425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boston Type 1 Keratoprosthesis for Gelatinous Drop-Like Corneal Dystrophy.
    Lekhanont K; Jongkhajornpong P; Chuephanich P; Inatomi T; Kinoshita S
    Optom Vis Sci; 2016 Jun; 93(6):640-6. PubMed ID: 26990741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.